Alexei A. Grom

16.9k total citations · 3 hit papers
122 papers, 7.4k citations indexed

About

Alexei A. Grom is a scholar working on Hematology, Immunology and Speech and Hearing. According to data from OpenAlex, Alexei A. Grom has authored 122 papers receiving a total of 7.4k indexed citations (citations by other indexed papers that have themselves been cited), including 100 papers in Hematology, 64 papers in Immunology and 38 papers in Speech and Hearing. Recurrent topics in Alexei A. Grom's work include Autoimmune and Inflammatory Disorders Research (100 papers), Immune Cell Function and Interaction (42 papers) and Adolescent and Pediatric Healthcare (38 papers). Alexei A. Grom is often cited by papers focused on Autoimmune and Inflammatory Disorders Research (100 papers), Immune Cell Function and Interaction (42 papers) and Adolescent and Pediatric Healthcare (38 papers). Alexei A. Grom collaborates with scholars based in United States, Italy and Switzerland. Alexei A. Grom's co-authors include Grant S. Schulert, Fabrizio De Benedetti, Alexandra H. Filipovich, Elizabeth Mellins, Murray H. Passo, Randy Q. Cron, Angelo Ravelli, Susan D. Thompson, Edward M. Behrens and Ndate Fall and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and Journal of Clinical Investigation.

In The Last Decade

Alexei A. Grom

116 papers receiving 7.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

On the Alert for Cytokine Storm: Immunopathology in COVID‐19

2020 475 citations Lauren A. Henderson, Scott Canna et al. Arthritis & Rheumatology profile →
Emapalumab in Children with Primary Hemophagocytic Lymphohistiocytosis

2020 311 citations Michael B. Jordan, Fabrizio De Benedetti et al. profile →
Interleukin-18 diagnostically distinguishes and pathogenically promotes human and murine macrophage activation syndrome

2018 261 citations Dirk Holzinger, Adriana A. de Jesus et al. Blood profile →

Peers

Alexei A. Grom

HEMAT

IMMUN

SURGE

Edward M. Behrens United States

David Webb United Kingdom

Athimalaipet V Ramanan United Kingdom

Gritta Janka Germany

Scott Canna United States

Isabelle Koné‐Paut France

Gerd Horneff Germany

Göran Elinder Sweden

Jordi Antón Spain

Tomoyuki Imagawa Japan

Edward M. Behrens United States

Alexei A. Grom

1.9k ×0.4

HEMAT

2.0k ×0.5

IMMUN

907 ×0.5

1.6k ×0.9

1.7k ×1.2

SURGE

Citations per year, relative to Alexei A. Grom Alexei A. Grom (= 1×) peers Edward M. Behrens

Countries citing papers authored by Alexei A. Grom

Since Specialization

Citations

This map shows the geographic impact of Alexei A. Grom's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alexei A. Grom with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alexei A. Grom more than expected).

Fields of papers citing papers by Alexei A. Grom

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alexei A. Grom. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alexei A. Grom. The network helps show where Alexei A. Grom may publish in the future.

Co-authorship network of co-authors of Alexei A. Grom

This figure shows the co-authorship network connecting the top 25 collaborators of Alexei A. Grom. A scholar is included among the top collaborators of Alexei A. Grom based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alexei A. Grom. Alexei A. Grom is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Brunner, Hermine I., Esraa M. Eloseily, Yonatan Butbul Aviel, et al.. (2024). Biomarker Changes in Response to Tofacitinib Treatment in Patients With Polyarticular‐Course Juvenile Idiopathic Arthritis. Arthritis Care & Research. 76(12). 1723–1732. 1 indexed citations

Maccora, Ilaria, Hermine I. Brunner, Amy Cassedy, et al.. (2024). Achieving Medication‐Free Remission in Patients With Juvenile Dermatomyositis. ACR Open Rheumatology. 7(1). e11751–e11751. 1 indexed citations

Baker, Elizabeth, Kashish Chetal, Daniel Schnell, et al.. (2023). Population-level single-cell genomics reveals conserved gene programs in systemic juvenile idiopathic arthritis. Journal of Clinical Investigation. 133(22). 3 indexed citations

Benedetti, Fabrizio De, Alexei A. Grom, Paul Brogan, et al.. (2023). Efficacy and safety of emapalumab in macrophage activation syndrome. Annals of the Rheumatic Diseases. 82(6). 857–865. 67 indexed citations

Brogan, Paul, et al.. (2023). P090 Protocol for the two-cohort, open-label, single-arm EMERALD study of emapalumab, an anti-interferon gamma monoclonal antibody, in patients with macrophage activation syndrome in rheumatic diseases. Lara D. Veeken. 62(Supplement_2).

Benedetti, Fabrizio De, et al.. (2023). AB1481 EMERALD STUDY DESIGN: A TWO-COHORT, OPEN-LABEL, SINGLE-ARM STUDY OF EMAPALUMAB, AN ANTI–INTERFERON-Γ (IFNΓ) MONOCLONAL ANTIBODY, IN PATIENTS WITH MACROPHAGE ACTIVATION SYNDROME (MAS) IN RHEUMATIC DISEASES. Annals of the Rheumatic Diseases. 82. 1969–1970.

Deutsch, Gail, Grant S. Schulert, Hong Zheng, et al.. (2022). Identification of Distinct Inflammatory Programs and Biomarkers in Systemic Juvenile Idiopathic Arthritis and Related Lung Disease by Serum Proteome Analysis. Arthritis & Rheumatology. 74(7). 1271–1283. 27 indexed citations

Grom, Alexei A., et al.. (2021). Trials in Progress: A Two-Cohort, Open-Label, Single-Arm Study of Emapalumab, an Anti-Interferon Gamma (IFNγ) Monoclonal Antibody, in Patients with Macrophage Activation Syndrome (MAS) in Rheumatic Diseases. Blood. 138(Supplement 1). 4195–4195. 3 indexed citations

Benedetti, Fabrizio De, Giusi Prencipe, Claudia Bracaglia, Emiliano Marasco, & Alexei A. Grom. (2021). Targeting interferon-γ in hyperinflammation: opportunities and challenges. Nature Reviews Rheumatology. 17(11). 678–691. 86 indexed citations

10.

Hur, Peter, Esther Yi, Raluca Ionescu‐Ittu, et al.. (2021). Reasons for Initiating Canakinumab among Patients with Systemic Juvenile Idiopathic Arthritis and Adult-Onset Still’s Disease in the U.S. Real-World Settings. Rheumatology and Therapy. 9(1). 265–283. 3 indexed citations

11.

Salomonis, Nathan, Alexei A. Grom, Sherry Thornton, et al.. (2021). IFN-γ is essential for alveolar macrophage–driven pulmonary inflammation in macrophage activation syndrome. JCI Insight. 6(17). 25 indexed citations

12.

Cheung, Peggie, Steven Schaffert, Sarah E. Chang, et al.. (2021). Repression of CTSG, ELANE and PRTN3-mediated histone H3 proteolytic cleavage promotes monocyte-to-macrophage differentiation. Nature Immunology. 22(6). 711–722. 45 indexed citations

13.

Holzinger, Dirk, Toni Weinhage, Claas Hinze, et al.. (2019). Synergistic Signaling of TLR and IFNα/β Facilitates Escape of IL-18 Expression from Endotoxin Tolerance. American Journal of Respiratory and Critical Care Medicine. 201(5). 526–539. 41 indexed citations

14.

Zeft, Andrew, Sampath Prahalad, Rayfel Schneider, et al.. (2017). Systemic onset juvenile idiopathic arthritis and exposure to fine particulate air pollution.. PubMed. 34(5). 946–952. 16 indexed citations

15.

Schulert, Grant S., et al.. (2017). Cat-Scratch Disease, a Diagnostic Consideration for Chronic Recurrent Multifocal Osteomyelitis. JCR Journal of Clinical Rheumatology. 24(5). 287–290. 4 indexed citations

16.

Barnes, Michael, Alexei A. Grom, Thomas A. Griffin, Robert A. Colbert, & Susan D. Thompson. (2010). Gene Expression Profiles from Peripheral Blood Mononuclear Cells Are Sensitive to Short Processing Delays. Biopreservation and Biobanking. 8(3). 153–162. 30 indexed citations

17.

Hinze, Claas, Ndate Fall, Sherry Thornton, et al.. (2010). Immature cell populations and an erythropoiesis gene-expression signature in systemic juvenile idiopathic arthritis: implications for pathogenesis. Arthritis Research & Therapy. 12(3). R123–R123. 42 indexed citations

18.

Grom, Alexei A. & Elizabeth Mellins. (2010). Macrophage activation syndrome: advances towards understanding pathogenesis. Current Opinion in Rheumatology. 22(5). 561–566. 140 indexed citations

19.

Filipovich, Alexandra H., Kenneth L. McClain, & Alexei A. Grom. (2009). Histiocytic Disorders: Recent Insights into Pathophysiology and Practical Guidelines. Biology of Blood and Marrow Transplantation. 16(1). S82–S89. 198 indexed citations

20.

Grom, Alexei A.. (2004). Natural killer cell dysfunction: A common pathway in systemic‐onset juvenile rheumatoid arthritis, macrophage activation syndrome, and hemophagocytic lymphohistiocytosis?. Arthritis & Rheumatism. 50(3). 689–698. 156 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact